✦ LIBER ✦

Long-term treatment with recombinant insulin-like growth factor 1 (IGF-1) in a child withIGF-1gene mutation

✍ Scribed by Daniela Concolino; Gianluca Muzzi; Simona Sestito; Giovanna Vega; Giuseppe Bonapace; Pietro Strisciuglio

Publisher: Springer
Year: 2009
Tongue: English
Weight: 92 KB
Volume: 169
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00431-009-1004-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant insulin-like growth factor-1

Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure

✍ Ross G. Clark 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 194 KB

Successful prolonged use of recombinant

Successful prolonged use of recombinant human insulin-like growth factor-1 in a child with cystic fibrosis

✍ Mark E. Haupt; Ellen E. Kim; Adrienne L. Prestridge 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

## Abstract Growth failure is a common and complicated process in children with cystic fibrosis (CF). Growth hormone, which is becoming a more commonly used agent in such patients, has demonstrated beneficial effects aside from increased growth velocity. Recently, insulin‐like growth factor‐1 has g

Does recombinant human insulin-like grow

Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?

✍ Dunger, D.B; Acerini, C.L. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

The structure of IGF-I is similar to that of insulin, having 43 % sequence homology with human proinsulin. Both peptides can induce metabolic and mitogenic effects through their own specific receptors, which also share many structural and functional similarities. Primarily involved in the regulation

Insulin-like growth factor type 1 (IGF–1

Insulin-like growth factor type 1 (IGF–1) and IGF binding protein–3 in patients with Ewing sarcoma family of tumors

✍ Jeffrey A. Toretsky; Seth M. Steinberg; Manjusha Thakar; Debra Counts; Baiba Pir 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 3 views

Insulin-like growth factor-1 receptor (I

Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neuoverexpressing metastatic breast cancer

✍ Wolfgang J. Köstler; Gernot Hudelist; Werner Rabitsch; Klaus Czerwenka; Ruth Mül 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 397 KB

Plasma insulin-like growth factor I and

Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen

✍ Eija I. Lahti; Mikael Knip; Timo J. Laatikainen 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

Background. Insulin-like growth factor I (IGF-I) is a potent mitogen for breast cancer cells. The majority of IGF-I in plasma is bound to IGF binding proteins (IGFBPs), which modulate the biologic effects of IGF-I. Methods. Plasma concentrations of IGF-I, IGFBP-I, and IGFBP-3 were compared between